• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叉头框蛋白O1(FoxO1)作为葛根素抑制破骨细胞生成和骨吸收的关键靶点。

FoxO1 as the critical target of puerarin to inhibit osteoclastogenesis and bone resorption.

作者信息

Feng Yanling, Tang Xulei

机构信息

Department of Endocrinology and Metabolism, The Second Hospital of Lanzhou University, Lanzhou 730030, China.

Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou 730000, China.

出版信息

J Pharm Pharmacol. 2024 Jul 5;76(7):813-823. doi: 10.1093/jpp/rgae033.

DOI:10.1093/jpp/rgae033
PMID:38554122
Abstract

BACKGROUND

Elevated reactive oxygen species levels promote excessive osteoclastogenesis and bone resorption. Puerarin, a natural antioxidant, can prevent bone loss through its antioxidant effects; however, the underlying molecular mechanism remains unclear. This study aimed to explore the effects of puerarin on osteoclast differentiation and bone resorption by regulating the PI3K/AKT/FoxO1 signaling pathway.

MATERIALS AND METHODS

An ovariectomized (OVX) rat model of osteoporosis and H2O2-induced oxidative cell model of RAW 264.7 cells were established. The following indices were measured including bone μ-CT scanning and the protein expression levels of FoxO1, p-FoxO1, and catalase were detected using western blotting.

RESULTS

Puerarin strongly alleviated oxidative stress-induced bone loss in OVX rats in vivo owing to its antioxidant effects. Puerarin improved the oxidative stress status of cells and inhibited osteoclast formation in vitro. Moreover, the protein expression of FoxO1 and its downstream target, catalase, was upregulated by puerarin.

CONCLUSIONS

Puerarin improved the OPG/RANKL ratio, upregulated the protein expression and transcriptional activity of FoxO1, and suppressed the differentiation of RAW264.7 cells into osteoclasts. FoxO1 is a pivotal target of puerarin to confer anti-osteoporosis effects.

摘要

背景

活性氧水平升高会促进破骨细胞过度生成和骨吸收。葛根素是一种天然抗氧化剂,可通过其抗氧化作用预防骨质流失;然而,其潜在的分子机制仍不清楚。本研究旨在通过调节PI3K/AKT/FoxO1信号通路来探讨葛根素对破骨细胞分化和骨吸收的影响。

材料与方法

建立去卵巢(OVX)大鼠骨质疏松模型和H2O2诱导的RAW 264.7细胞氧化应激细胞模型。测量以下指标,包括骨μ-CT扫描,并使用蛋白质印迹法检测FoxO1、p-FoxO1和过氧化氢酶的蛋白表达水平。

结果

葛根素因其抗氧化作用在体内显著减轻了氧化应激诱导的OVX大鼠骨质流失。葛根素改善了细胞的氧化应激状态,并在体外抑制了破骨细胞的形成。此外,葛根素上调了FoxO1及其下游靶点过氧化氢酶的蛋白表达。

结论

葛根素提高了OPG/RANKL比值,上调了FoxO1的蛋白表达和转录活性,并抑制了RAW264.7细胞向破骨细胞的分化。FoxO1是葛根素发挥抗骨质疏松作用的关键靶点。

相似文献

1
FoxO1 as the critical target of puerarin to inhibit osteoclastogenesis and bone resorption.叉头框蛋白O1(FoxO1)作为葛根素抑制破骨细胞生成和骨吸收的关键靶点。
J Pharm Pharmacol. 2024 Jul 5;76(7):813-823. doi: 10.1093/jpp/rgae033.
2
Resveratrol prevents osteoporosis by upregulating FoxO1 transcriptional activity.白藜芦醇通过上调 FoxO1 转录活性预防骨质疏松症。
Int J Mol Med. 2018 Jan;41(1):202-212. doi: 10.3892/ijmm.2017.3208. Epub 2017 Oct 23.
3
Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.白杨素 A 通过抑制 NF-κB 和 Akt 通路抑制 RANKL 诱导的破骨细胞生成和卵巢切除诱导的骨质疏松症。
J Ethnopharmacol. 2021 Aug 10;276:114176. doi: 10.1016/j.jep.2021.114176. Epub 2021 Apr 30.
4
Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways.葛根素通过抑制 TRAF6/ROS 依赖性 MAPK/NF-κB 信号通路抑制破骨细胞生成来缓解去卵巢诱导的骨质疏松症。
Aging (Albany NY). 2020 Nov 7;12(21):21706-21729. doi: 10.18632/aging.103976.
5
Resveratrol promotes osteogenesis via activating SIRT1/FoxO1 pathway in osteoporosis mice.白藜芦醇通过激活 SIRT1/FoxO1 通路促进骨质疏松症小鼠的成骨作用。
Life Sci. 2020 Apr 1;246:117422. doi: 10.1016/j.lfs.2020.117422. Epub 2020 Feb 11.
6
Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K-AKT-NFATc1 pathway.雷公藤内酯醇通过抑制 PI3K-AKT-NFATc1 通路抑制破骨细胞生成来防止骨质流失。
J Cell Mol Med. 2020 Jun;24(11):6149-6161. doi: 10.1111/jcmm.15229. Epub 2020 Apr 28.
7
Dietary Puerarin Translocates to Femur and Suppresses Osteoclast Differentiation in Ovariectomized Mice.葛根素膳食可转移至股骨并抑制去卵巢小鼠破骨细胞分化。
J Nutr Sci Vitaminol (Tokyo). 2024;70(3):262-272. doi: 10.3177/jnsv.70.262.
8
New mechanistic understanding of osteoclast differentiation and bone resorption mediated by P2X7 receptors and PI3K-Akt-GSK3β signaling.新型机制:P2X7 受体和 PI3K-Akt-GSK3β 信号通路介导的破骨细胞分化和骨吸收。
Cell Mol Biol Lett. 2024 Jul 8;29(1):100. doi: 10.1186/s11658-024-00614-5.
9
Curculigoside Protects against Excess-Iron-Induced Bone Loss by Attenuating Akt-FoxO1-Dependent Oxidative Damage to Mice and Osteoblastic MC3T3-E1 Cells.毛蕊花糖苷通过减轻 Akt-FoxO1 依赖性氧化损伤来保护小鼠和成骨细胞 MC3T3-E1 抵抗过量铁诱导的骨丢失。
Oxid Med Cell Longev. 2019 Dec 17;2019:9281481. doi: 10.1155/2019/9281481. eCollection 2019.
10
Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL-induced osteoclastogenesis.金雀花堿通过抑制 RANKL 诱导的破骨细胞生成来减轻去卵巢小鼠的骨丢失。
J Cell Mol Med. 2020 Sep;24(17):10112-10127. doi: 10.1111/jcmm.15622. Epub 2020 Aug 13.

引用本文的文献

1
Exploring the Potential of in Managing Bone Loss: Insights from Preclinical Studies.探索[具体内容]在管理骨质流失方面的潜力:来自临床前研究的见解。 (注:原文中“Exploring the Potential of in Managing Bone Loss”里有个空格处应补充具体内容)
Int J Med Sci. 2025 Jan 21;22(4):819-833. doi: 10.7150/ijms.103241. eCollection 2025.
2
Cellular senescence: A new perspective on the suppression of periodontitis (Review).细胞衰老:抑制牙周炎的新视角(综述)。
Mol Med Rep. 2024 Dec;30(6). doi: 10.3892/mmr.2024.13362. Epub 2024 Oct 18.